Recipient of federal assistance · BOSTON, MA

EIP PHARMA, INC.

EIP PHARMA, INC. received -$182.7K in federal grants and other assistance in FY2026, on 2 actions, −103% vs FY2025. It has no federal contracts in the loaded years. Since FY2023: $20.9M.

Assistance · FY2026
-$182.7K
New awards
0
Actions
2
Since FY2023
$20.9M
UEI
ZHHVJ1KU1NA1
Location
BOSTON, MA
Businesses
Open in the explorerFederal grants & assistance

Federal grants & assistance received

Grants, loans (counted at their subsidy cost), direct payments and insurance, by fiscal year of the action (USAspending.gov, FABS). Reported apart from contracts and never added to them.

Assistance by fiscal year

  1. 6.7MFY2023
  2. 8.3MFY2024
  3. 6.1MFY2025
  4. -182.7KFY2026

By type

  1. Grants-$182.7K0.0%

Top programs · Awarding agencies

Obligations in FY2026.

Top programs

  1. 93.866 · Aging Research-$182.7K0.0%

Largest awards

  1. A PHASE 2B CLINICAL STUDY OF THE P38 ALPHA KINASE INHIBITOR NEFLAMAPIMOD IN PATIENTS WITH MILD-TO-MODERATE DEMENTIA WITH LEWY BODIES (DLB)…$20.9M
    93.866 · Aging Research· National Institutes of Health· Project grant· Jan 18, 2023 – Aug 10, 2026· R01AG080536

Source: Federal financial assistance transactions (Financial Assistance Broker Submission) (U.S. Department of the Treasury, USAspending.gov), data current to Oct 6, 2026, loaded Oct 6, 2026 · FY2023–FY2026.